MBMustafa Bilici

Mustafa Bilici

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mustafa Bilici has a total of 87 co-authors. Here are the top co-authors by number of shared publications:

  • Hasim Cakirbay

    BlackSea Technical University School of Medicine Department of Psychiatry Trabzon, Turkey

    3 shared publications
  • Mehmet Tosun

    BlackSea Technical University School of Medicine Department of Physical Medicine and Rehabilitation Trabzon, Turkey

    3 shared publications
  • Mustafa Guler

    BlackSea Technical University School of Medicine Department of Physical Medicine and Rehabilitation Trabzon, Turkey

    3 shared publications
  • Uner Tan

    BlackSea Technical University School of Medicine Department of Psychiatry Trabzon, Turkey

    3 shared publications
  • C Soylu

    Department of Psychiatry, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey

    2 shared publications
  • M. Arif Koroglu

    Department of Psychiatry, BlackSea Technical University, 61080, Trabzon, Turkey

    2 shared publications

Latest Publications

  • Open Access

    Bilişsel Psikoloji Perspektifinden Din ve Maneviyat

    by Büşra Şekerli, Mustafa Bilici

    Din ve maneviyat kavramları geçmişten günümüze bilim dünyasında tartışılmaya devam etmektedir. Tarih boyunca din ve bilim ilişkisi çeşitli biçimlerde ele alınmıştır. Yinger’in (1957) din ve bilimin dört şekilde ilişkili olabileceğini ifade etmiştir. Buna göre (i) birbirleriyle uyum içerisinde olabilirler; (ii) aslında din ve bilim birbiriyle aynı anlama gelebilir; (iii) birbirlerinden tamamen ayrı oldukları için aralarında temel bir çatışma söz konusu olmaz; (iv) bilim gerçeğin tek ölçüsü şeklinde kabul edilir ve dinin bilimle çelişen hükümleri bilim adına geçersiz kabul edilerek reddedilebilir. Din kavramının bilim dünyasında nasıl ele alınması gerektiği ile ilgili çeşitli görüşler olmasına rağmen felsefe, sosyoloji, psikoloji, antropoloji gibi birçok disiplin din konusun-da açıklamalar yapmıştır. Uygulamalı bilimlerden biri olan biliş-sel psikoloji de din üzerine araştırmalar yapan bilim alanlarından biridir. Bilişsel psikoloji, din üzerine çalışmalar yaparken dinle ilgili davranışların sadece gözlenen durumla sınırlandırılamaya-cağını, zihinsel temsiller ve inançlar gibi zihinsel süreçlere de odaklanılması gerektiğini ifade etmektedir. Bu makalenin amacı, bilişsel psikolojinin din ve maneviyat konularına ilişkin açıklamalarını ve bu alandaki önde gelen çalışmaları derlemek ve bireyin din ve maneviyatla ilgili gelişimini bilişsel psikoloji perspektifin-den incelemektir. Bu makalede, genel olarak bilişsel psikolojinin tarihçesi, bilişsel psikoloji ve din ilişkisi, dinsel biliş, dini gelişim kuramları ve bilişsel psikoloji, Piaget’nin bilişsel gelişim kuramı ve din, üst biliş, din ve maneviyat ilişkisi son olarak da bilişsel psikoloji ve din arasındaki ilişkileri açıklamaya yönelik bazı araştırmalar betimlenmiştir. Bireyin dini gelişimini ve maneviyatla ilişkisini açıklamada en sık ve yaygın kullanılan bilişsel psikoloji kuramı, Piaget’nin bilişsel gelişim kuramıdır. Elkind ve Goldman gibi alandaki önde gelen kuramcılar ise Piaget’nin kuramın-dan yararlanmışlar ve açıklamalarını zihinsel gelişim evrelerine benzer şekilde evre temelli oluşturmuşlardır. Üst biliş, din ve maneviyat arasındaki ilişkileri saptamak için yapılan çalışmalara bakıldığında ise Flavell, Wells, Brown, Schraw ve Moshman gibi kuramcıların ön plana çıktığı görülmüştür. Sonuç olarak konuya ilişkin yapılan çalışmalara bakıldığında, genel olarak üst biliş ile din ve maneviyat arasında pozitif yönlü ilişkilerin olduğu söylenebilir.


  • Anxiety and theory of mind: A moderated mediation model of mindfulness and gender

    by Gülşah Balaban, Mustafa Bilici

    This study aimed to examine the relationship between gender, anxiety, mindfulness, and theory of mind (ToM). It was also aimed to investigate the mediating role of mindfulness in the relationship between anxiety and ToM. Additionally, the moderating role of gender in the relevant relationships was examined. The sample consisted of 323 people, including 260 (80.5%) females and 63 (19.5%) males, aged between 18‐62 years. Data were collected by the Reading the Mind in the Eyes Test, the State‐Trait Anxiety Inventory II, and the Mindful Attention Awareness Scale. It was found that ToM and anxiety levels were statistically significantly higher in women than men. In the regression analysis, it was detected that mindfulness predicts the 7% variance in ToM. The second predictor of ToM was found as anxiety, and both predictors explained the 9% variance in ToM. In the mediating analysis, it was found that mindfulness has a mediating role in the relationship between anxiety and ToM. In the moderated mediation analysis, it was determined that the pathway between anxiety and ToM was moderated by gender; the moderating role of gender also was found between mindfulness and ToM. In light of these findings, experimental future studies can be suggested with clinical samples for a better understanding of the relationships between gender, anxiety, mindfulness, and ToM.


  • Open Access

    Nitric oxide, asymmetric dimethylarginine, symmetric dimethylarginine and L-arginine levels in psychotic exacerbation of schizophrenia and bipolar disorder manic episode

    by Mehmet F. Ustundag, Halil Ozcan, Ali G. Gencer, Enver D. Yilmaz, Kerim Uğur, Elif Oral, Mustafa Bilici

    Nitric oxide, asymmetric dimethylarginine, symmetric dimethylarginine and L-arginine levels in psychotic exacerbation of schizophrenia and bipolar disorder manic episode


  • Electroacupuncture Therapy in Nicotine Dependence: A Double Blind, Sham-Controlled Study

    by Mustafa Bilici, Sertac Guven, Selcen Kosker, Ayse Safak, Umit Basar Semiz

    The number of non-pharmacological controlled studies is insufficient in the treatment of nicotine dependence (ND). Nevertheless, non-pharmacological treatments, such as electroacupuncture (EA), are becoming increasingly popular in the treatment of ND. The aims of this study were to determine the efficacy and safety of "true EA therapy" (TEAT) compared to those of "sham EA therapy" (SEAT) in ND treatment. Eligible patients who met the DSM-IV criteria for ND (n=450) were included in the study. This study was a double-blinded, sham-controlled clinical trial with a 4-week treatment period and 4-week follow-up conducted between June and December 2009 at a psychiatry outpatient clinic. One hundred and sixty four adult (≥18 years; 44 men, 120 women) cigarette smokers out of 450 patients who met the inclusion and exclusion criteria were enrolled in the study in a ratio of 1:1 to receive TEAT (n=84) or SEAT (n=80). Routine biochemical and hematological tests, chest X-Ray, and ECG were carried out; end-expired carbon monoxide (CO) levels were measured too. Clinical characteristics were obtained through the Fagerström Nicotine Dependence Test (FNDT), Hamilton Rating Scale for Depression (HRSD), and Hamilton Anxiety Scale (HAS). EA was carried out by a trademark device, Antismoke 3000®. Efficacy analyses were performed on "intent-to-treat analysis." Primary outcome was the differences from baseline to endpoint in mean FNDT, number of cigarettes smoked per day, and CO levels at week 4. Secondary outcomes were the same variables at week 8. These variables were assessed via analysis of covariance (ANCOVA). Mean baseline FNDT, HRSD, HAS, and CO levels of the groups were statistically similar. TEAT and SEAT groups demonstrated no significant changes in the outcome variables and smoking cessation rates (35.7% and 30%, respectively). Of those remaining outside of the study, 8.3% were from the TEAT group and 8.7% were from the SEAT group; there was no statistical difference between the groups. The rate of treatment discontinuation was similar between the TEAT (44%) and SEAT (43.7%) groups (p>0.05). The rates of adverse events were not similar too. This study showed that both TEAT and SEAT have similar efficacy and safety profiles in patients with ND.


  • Electroencephalography Spectral Power Density in First-Episode Mania: A Comparative Study with Subsequent Remission Period

    by Sertac Guven, Sermin Kesebir, R. Murat Demirer, Mustafa Bilici

    Electrophysiological corollary of mood episode is present from the onset of the disease, and it differs between the manic and remission periods of bipolar disorder. In the remission period, peak power values of PSD distinguish cases with psychotic findings from cases without psychotic findings when they were manic.


  • Effects of paliperidone extended release on functioning level and symptoms of patients with recent onset schizophrenia: An open-label, single-arm, flexible-dose, 12-months follow-up study

    by Alp Üçok, Meram Can Saka, Mustafa Bilici

    Background: Response to antipsychotic treatment is better in the early stages of schizophrenia. Aims: The primary objective of this non-randomized, single-arm, multicenter clinical trial was to explore the response to treatment and safety of a flexible dose of paliperidone (mean = 6.42 mg/day) in patients with recent onset schizophrenia (< 3 years after the first episode/hospitalization). Methods: Severity of clinical symptoms was evaluated by the Positive and Negative Syndrome Scale (PANSS), functioning was assessed using the Global Assessment of Functioning (GAF) scale and the Personal and Social Performance Scale (PSP). Results: In a total of 85 patients enrolled, 80 patients were eligible. Total PSP score at baseline (50.2 ± 11.6) increased at all visits. Total PSP score was 65.4 ± 12.1 at month 12 (P < 0.001). GAF scores were significantly higher at all visits compared with baseline (P = 0.001). It was 62.4 ± 12.5 with an increase of 42.9% at month 12 (P < 0.001). PANSS Positive and Negative subscales and General psychopathology subscale scores showed significant reductions beginning with month 3 and were 11.9 ± 3.8 (29.3%; P < 0.001), 13.7 ± 5.6 (27.3% P < 0.001) and 27.8 ± 7.1 (23.2%; P < 0.001) at month 12, respectively. Twelve patients (14.3%) had a serious adverse event. The most common adverse events were insomnia (17.9%), nausea (8.3%), akathisia (4.8%), anxiety (4.8%) and depression (4.8%). Body weight values at the end of the study were significantly higher compared with baseline. Conclusion: The present study demonstrates that flexible dose of paliperidone resulted in a significant improvement in functioning and reduction in symptoms in patients with recent onset schizophrenia.


  • İki Uçlu Bozuklukta Duygudurum Düzenleyici Tedavi Modaliteleri Arasında Cinsel İşlev ve Hormonal Değişkenlerin Karşılaştırılması

    by Sermin Kesebi̇r, Burak Toprak, Burak Baykaran, Aytül Hari̇ri̇, Mustafa Bi̇li̇ci̇

    The aim of this study was to determine the differences between lithium and atypical antipsychotics (quetiapine and olanzapine) with regard to their effects on sexual functions and hormonal variables and to assess the findings in term of gender differences, in patients with bipolar disorder. 28 female and 29 male patients diagnosed as having bipolar disorder type I according to the DSM-IV, using lithium or quetiapine and quetiapine+lithium or olanzapine and olanzapine+lithium were evaluated consecutively. Being in remission period and given informed consent were set as inclusion criteria in these cases. Interviews with the patients were carried out using the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I) and SKIP-TURK. Sexual functions and satisfaction were evaluated with the Arizona Sexual Experiences Scale (ASEX) and the Golombok Rust Inventory of Sexual Satisfaction (GRISS). Blood samples of the patients were taken in order to determine prolactin (PRL), follicle-stimulating hormone (FSH), luteinizing hormone (LH), estradiol (E2), and free testosterone (T) levels. GRISS scores in male patients were higher than in female patients (p=.001). The number of manic, depressive and total episodes, and functionality levels were similar between the treatment groups, both in female and male patients. No differences were found between treatment modalities in terms of hormone levels both in female and male patients. Among females, ASEX scores of the patients treated with lithium monotherapy were less than the ones treated with quetiapine and olanzapine. Among patients with quetiapine monotherapy, GRISS scores in male patients were higher than in female patients. There are some evidences showing gender-based differences in the side effects of atypical antipsychotic drugs. Future studies with a specific focus on this topic are needed in order to have a better understanding of the basic mechanisms of gender differences.


  • Low plasma adiponectin levels in panic disorder

    by Cuneyt Unsal, Aytul Gursu Hariri, Omer Yanartas, Ergun Sevinc, Murad Atmaca, Mustafa Bilici


  • Open Access

    KRAEPELİN ÖLÇÜTLERİNE UYAN ŞİZOFRENİ HASTALARINDA KLİNİK, NÖROKOGNİTİF, YAPISAL GÖRÜNTÜLEME VE DERMATOGLİFİK ÖZELLİKLER

    by Hüseyin Güleç, Semra Ulusoy Kaymak, Mustafa Bilici, Ali Gangal, Temel Kayikç Ioğlu, Ahmet Sari, Üner Tan

    A century ago, Kraepelin stated that the distinctive feature of schizophrenia was progressive deterioration. Kraepelin criteria for schizophrenia are: (1) continuous hospitalization or complete dependence on others for obtaining basic necessities of life, (2) unemployment and (3) no remission for the past five years. We aimed to determine the clinical appearance and structural biological features of Kraepelinian schizophrenia. The sample consisted of 17 Kraepelinian patients, 30 non-Kraepelinian schizophrenic patients and 43 healthy controls. The Clinical Global Impressions (CGI) and the Positive and Negative Syndrome Scales (PANSS) were used for clinical assessment. The Frontal Assessment Battery (FAB) and the Verbal Fluency and Color Trail Test (CTT) were included in the cognitive battery. Brain magnetic resonance imaging and dermatoglyphic measurements were performed for structural features. Duration of illness, hospitalization, suicide attempts, admission type, presence of a stressor and treatment choice were similar between the two patient groups. Treatment resistance and family history of schizophrenia were more common in Kraepelinian patients. PANSS and CGI subscales scores were also higher in this group. Only the category fluency and CTT-I were different in Kraepelinian patients in comparison to the other patient group. Structural findings were not different between the three groups. Category fluency, which was lower in Kraepelinian patients, is an important marker of a degenerative process. The collection of severe clinical symptoms, family history of psychiatric illness and nonresponse to treatment in this particular group of patients points to the need to conduct further studies including cluster analysis in methodology.